IntroDuctIon
Neoplastic tumor cells and host-derived stromal cells coexist in carcinomas. Clinical and preclinical evidence supports the contribution of these nonmalignant stromal cells to the development of tumors [1] [2] [3] [4] [5] [6] . Many studies have shown that solid tumors actively recruit these stromal cells to create a microenvironment that promotes primary tumor growth and dissemination [7] [8] [9] [10] . Moreover, this process is likely to be repeated when tumors colonize secondary sites during metastatic growth.
A tumor cell from the primary tumor can lead to established metastases when it successfully completes each of the sequential and interrelated steps of the metastatic cascade. Each of these steps can be rate limiting, and failure to complete a step can abrogate the entire process 11 . Recent studies have shown that the host-derived stroma may increase the efficiency of this complex system. Among the stromal cell types that have been linked to tumor promotion and progression are endothelial cells, pericytes, fibroblasts and various bone marrow-derived cells, including splenocytes, macrophages, neutrophils, mast cells, myeloid-derived suppressor cells and mesenchymal stem cells 6, 12, 13 . Metastatic cells could reside in the lungs awaiting oncogenic activation 14 , or could home to pre-existing niches created by inflammation and immune cell or fibroblast accumulation [15] [16] [17] [18] . In addition, it has been shown that metastatic cells proliferate intravascularly before extravasation into the lung tissue 19 .
Previous applications of the protocol
Studies reported more than 30 years ago showed that cancer cell clumping in circulation increases metastasis 20, 21 . These clumps may be emboli, formed in circulation because of interactions with immune cells 11, 22, 23 . Indeed, the injection of emboli-containing tumor cells increases the efficiency of metastasis. However, the clumps may also be fragments consisting of tumor cells that carry 'passenger' stromal cells from the primary site. By using the techniques described in this protocol in combination with two spontaneous metastases models-one using skin transplantation by transient parabiosis and a second using carcinoma-associated fibroblasts to selectively deplete stromal cells 24, 25 -we have recently shown that these host-derived cells increase tumor cell viability in circulation and serve as a provisional stroma in the secondary site and increase the cancer's metastatic efficiency 26 .
Overview of the technique
The technique described in this protocol can be used to study circulating tumor cells originating from any primary tumor. Tumors can be implanted orthotopically or ectopically, and non-tumor-bearing mice are used as a control. Here we use the renal perfusion model in combination with primary tumor implantation in the renal capsule. Implanting tumors at different (orthotopic) sites might provide additional insights in assays of mestastasis, and they could be adapted from previously established isolated tumor models. These include transplanted and spontaneous breast cancer, ovarian cancer and liver cancer models [27] [28] [29] [30] . The experimental design of the protocol used is depicted in Figure 1 . To study tumor cells and fragments shed by the primary tumor, we implant fluorescent-labeled tumor cells in the kidney capsule. After 12 d, we use the isolated kidney-tumor perfusion model to collect tumor cells and fragments that were shed by the primary tumor. By monitoring blood pressure in the carotid artery and adjusting the perfusion rate through the jugular vein, we are able to collect tumor perfusate for up to an hour, yielding 3-4 ml of blood per mouse.
Comparison with other techniques
Several in vitro assays have been developed to study host-tumor cell interactions related to progression and invasion 31, 32 , including the chemoinvasion assay using the reconstituted BD Matrigel in Boyden blind-well chambers. It can be applied to detect the migratory activity associated with matrix degradation and can also be adapted to study the selective degrading activity on different matrix substrates. The advantage of this in vitro assay is the ease of controlling different parameters in the experiment. At the same time, the lack of in vivo microenvironmental factors may confound the results. Many in vivo models have been used to examine the role of stromal components within the primary tumor microenvironment. Human mammary tissue can be reconstructed in a mouse model to study cross talk between tissue stroma and the epithelium, as well as factors involved in breast stem cell biology of tumor initiation and progression 33 . However, there is a paucity of techniques for studying and visualizing primary tumor stromal cells in different steps of the metastatic process. We have developed an experimental protocol that can be used to quantitatively study the contribution of stromal cells to tumor fragment survival [28] [29] [30] 34, 35 . We have used this model to unravel the role of 'passenger' fibroblasts in tumor metastasis to the lungs 26 . However, other tumor stromal cells could potentially be studied using this protocol.
Advantages and limitations
The key advantage of our protocol over other existing methods is that one can gain the ability to image and quantify in vivo all cells and fragments that are shed by the kidney, liver, ovary and inguinal gland during metastasis. Alternatively, one could use the collected cells/fragments for consecutive in vivo experiments in which the effect of drugs on tumor cell/clump shedding could be studied.
The major limitation of this technique is that animals have to be exsanguinated. In addition, a large number of mice are required to study the effects of therapy over time.
The renal perfusion model shown here is an ectopic tumor model, where tumors are implanted surgically in the renal capsule. However, other organs or tissues could, in principle, be used to collect efferent cells.
A further potential disadvantage is that the studies require GFP + or other transgenic immunocompetent mice, which can only be used with certain (syngeneic) tumor lines. proceDure tumor implantation in the left kidney 1| Anesthetize a male Actb-GFP/C57BL/6 mouse, 6-10 weeks of age, using an intramuscular injection of 0.4 ml of ketamine/xylazine and place it on a heating pad.
2|
Position the mouse on the heating pad with the left flank facing the surgeon. Make an 8-mm incision through the skin and muscle layers approximately 1 cm lateral to the spine and 3 mm dorsal to the lowest ribs. Externalize the left kidney using applicator tips. ? trouBlesHootInG 3| Create a small pocket under the renal capsule using the tip of the micro syringe. Inject 1 × 10 6 LLC1-dsRed tumor cells in 0.1 ml of Hank's balanced salt solution in the renal capsule using a 30-G needle. ? trouBlesHootInG 4| Remove any liquids that are leaking out of the capsule using an applicator tip.
5|
Close the muscle layers and skin using 5-0 Ethibond sutures. Keep the mice in appropriate cages under sterile conditions and allow the tumors to grow to 8 mm.
6|
At the preferred time point (e.g., 2 weeks after implantation of LLC1 tumors), anesthetize the mouse using an intramuscular injection of 0.4 ml of ketamine/xylazine and keep it on a heating pad.
7|
Open the abdomen by laparatomy to inspect the location of the kidney tumor. Reposition the organs and cover the abdomen with skin and a sponge before moving to the next step. ? trouBlesHootInG cannulation of the carotid artery 8| Position the mouse on its back, with the mouse's head facing the surgeon. Fix the head by taping it across the nose and fix the body by taping across the paws and the sternum (Fig. 2a). 9| Make a midline incision under the chin, exposing the salivary glands. Expose the trachea by separating the salivary glands sideways using the micro forceps (Fig. 2b) .
10| Dissect the muscles overlying the carotid artery using microdissection forceps and dissection microscope.  crItIcal step It is important to remove all the connective tissue surrounding the carotid artery, as this facilitates cannulation.
11|
Loop two 6-0 silk sutures around the artery, 5 mm apart, and then close the cranial ligature. Make a loose knot in the caudal suture (Fig. 2c) .
12|
Apply the hemostatic clamp onto the carotid artery caudal to the loose knot (Fig. 2c) .
13|
Connect the heparin-filled PE10 tubing to a three-way stopcock and pressure transducer through a 30-G needle. While holding the cranial suture, cut across one-third of the carotid vessel wall with microscissors, and then insert the heparin-filled PE10 tubing into the vessel toward the hemostatic clamp. 21| Access the abdominal cavity through the previously performed laparatomy.
22|
Move and hold all the organs to the right side using a wet sponge to clear the field for the cannulation of the left renal vein.
23|
Locate the left adrenal vein and testicular vein draining into the renal vein and ligate both to avoid rupture. Use two 6-0 silk sutures to ligate the branches and cut in between to create a space to move the renal vein around.
24|
Dissect the connective tissue around the renal vein to locate the renal artery, which is behind the vein, and then separate the two. 26| Collect the dripping perfusate into the 15-ml collection tube kept on ice, and increase the Oxyglobin flow to maintain a physiological pressure between 60 and 100 mm Hg. Oxygenation of the perfusate solution is achieved by a gas exchanger in which the perfusate is led through 16 feet of silastic tubing while being equilibrated with warm humidified 95% O 2 and 5% CO 2 . During the experiment, keep the perfusate in a heated bath and lead it through the gas exchanger and then into the jugular vein into the mouse's circulation. ? trouBlesHootInG
27|
Cover the open abdomen with a wet sponge for the remaining time of the experiment, up to 1 hour. ? trouBlesHootInG ? trouBlesHootInG Troubleshooting advice can be found in table 1.
• tIMInG Step 27, collection of perfusate: 1 h antIcIpateD results Figure 2 shows some typical results of the renal perfusion model. Heterogeneous tumor and stromal cell clumps can be detected in the filtered perfusate using a fluorescence microscope (Fig. 2) . These harvested clumps and single cells can be further studied for viability, composition or expression of specific proteins of interest. In our study, the vast majority (~81%) of the shed dsRed + cancer cells were single cells (Fig. 3a) . However, we also collected small tumor clumps (≤200 µm in diameter), and all tumor clumps composed of six or more cells contained GFP-expressing host cells (Fig. 3a) . In addition, caspase 3 and caspase 7 activation-a measure of apoptosis-was detectable in most (~88%) of the single or doublets of cancer cells at the time of shedding. In contrast, the heterotypic cell clumps contained almost twice as many viable cancer cells (22.8 ± 4.5%, P < 0.05; see Fig. 3b ). The clumps can be used for consecutive in vitro or in vivo experiments to study the effect of antimetastatic drugs on tumor cell clumping and viability (Fig. 4) .
50 µm 100 µm a b 
